Cite

HARVARD Citation

    Munhoz, R. et al. (2022). A phase 2 study of first‐line nivolumab in patients with locally advanced or metastatic cutaneous squamous‐cell carcinoma. Cancer. 128 (24), pp. 4223-4231. [Online]. 
  
Back to record